Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors
Clinical trial NCT07106814 · RECRUITING
Trial details
- NCT number
- NCT07106814
- Sponsor
- Anhui Provincial Hospital
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-29
- Primary completion
- 2027-08-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.